Collins Cooper C.

Average Profitability
<0.0001%
Insider Buys Quantity
9
Insider Buys Sum
$1.87M
Insider Sells Quantity
1
Insider Sells Sum
$9.21M

Insider Activity of Collins Cooper C.

According to the SEC Form 4 filings, Collins Cooper C., being in a position of

  1. director at TherapeuticsMD, Inc.,
    оver the last 12 months, has bought 5294 shares for $9,138, and sold 0 shares,
    over all time since 2013-06-14, has bought 2181294 shares for $1.87M, and sold 5263158 shares for $9.21M.

The largest purchase of all time was on 2021-08-18 and amounted to 900000 shares of TherapeuticsMD, Inc. for $648,000.

The largest sale of all time was on 2013-06-14 and amounted to 5263158 shares of TherapeuticsMD, Inc. for $9.21M.

Biography of Collins Cooper C.

No biography is available at this moment.

2024-08-22PurchaseTherapeuticsMD, Inc.
TXMD
director
4,094
0.0352%
$1.73$7,099-0.57%
2024-08-21PurchaseTherapeuticsMD, Inc.
TXMD
director
1,200
0.0105%
$1.70$2,039+3.55%
2021-11-18PurchaseTherapeuticsMD, Inc.
TXMD
director
1M
0.0046%
$0.58$578,500-65.74%
2021-08-18PurchaseTherapeuticsMD, Inc.
TXMD
director
900,000
0.0043%
$0.72$648,000-54.17%
2021-08-17PurchaseTherapeuticsMD, Inc.
TXMD
director
100,000
0.0005%
$0.77$77,000-56.49%
2020-06-08PurchaseTherapeuticsMD, Inc.
TXMD
director
74,000
0.0005%
$1.45$107,300-8.05%
2019-05-13PurchaseTherapeuticsMD, Inc.
TXMD
director
30,000
0.0003%
$3.33$99,870-24.24%
2016-03-11PurchaseTherapeuticsMD, Inc.
TXMD
director
32,000
0.0003%
$6.23$199,434-0.44%
2014-06-05PurchaseTherapeuticsMD, Inc.
TXMD
director
40,000
0.0005%
$3.84$153,780+18.78%
2013-06-14SaleTherapeuticsMD, Inc.
TXMD
director
5.26M
0.0497%
$1.75$9.21M+50.18%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.